LifeMD, Inc.
LFMD
$3.40
$0.133.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -5.75% | 7.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.75% | 7.03% | |||
| Cost of Revenue | -10.82% | -1.66% | |||
| Gross Profit | -5.07% | 8.31% | |||
| SG&A Expenses | -8.02% | 30.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -4.94% | -6.42% | |||
| Total Operating Expenses | -7.92% | 23.20% | |||
| Operating Income | 20.15% | -713.44% | |||
| Income Before Tax | 20.16% | -726.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.16% | -715.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.16% | -144.44% | |||
| EBIT | 20.15% | -713.44% | |||
| EBITDA | 20.94% | -997.64% | |||
| EPS Basic | 19.28% | -149.68% | |||
| Normalized Basic EPS | 20.92% | -742.45% | |||
| EPS Diluted | 19.28% | -149.76% | |||
| Normalized Diluted EPS | 20.92% | -742.45% | |||
| Average Basic Shares Outstanding | 0.96% | 1.20% | |||
| Average Diluted Shares Outstanding | 0.96% | 1.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.25% | -3.25% | |||